*

Hitt og þetta 27. apríl 2006

Annual General Meeting in Pharmexa A/S

The General Meeting approved the report of the Board of Directors and the Financial Statements.

The Board of Directors' motion that the loss for the year of KDKK 118,067 is offset against the share premium was approved.

The Board of Directors' proposal in relation to the Board of Directors' authorisation for the period ending December 31, 2007 to increase the share capital by one or more issues with a nominal value of up to DKK 412,707,600 was approved.

The Board of Directors were authorised to issue warrants in accordance with the submitted proposal.

The proposed amendments to Articles 4.1, 4.6, and 4.7 in the Articles of Association were approved.

Michel L. Pettigrew was elected to the Board of Directors and Karl Olof Borg, Jørgen Buus Lassen, Alf A. Lindberg and Arne Gillin were re-elected to the Board of Directors.

The company has decided to have one accountant and Ernst & Young, Statsautoriseret Revisionsaktieselskab was re-elected.

Hørsholm, April 27, 2006

Jakob Schmidt Chief Executive Officer